宫颈癌新辅助化疗(Neoadjuvant chemotherapy，NACT)是指患者在手术或放疗前所进行的一定疗程的化疗，属于辅助性治疗范畴。
基于12个网页-相关网页
胃癌新辅助化疗 neoadjuvant chemotherapy for gastric cancer
乳腺癌新辅助化疗 neoadjuvant chemotherapy ; NACT ; NAC
宫颈癌新辅助化疗 neoadjuvant chemotherapy
与乳腺癌新辅助化疗 neoadjuvant chemotherapy
以及乳腺癌新辅助化疗 NAC
宫颈癌的新辅助化疗 neoadjuvant chemotherapy ; NACT
乳腺癌的新辅助化疗 neo adjuvant chemotherapy ; NCT
宫颈癌术前新辅助化疗 Neoadjuvant Chemotherapy ; NACT
前言：目的：探讨紫杉醇联合顺铂(TP)对局部晚期宫颈癌新辅助化疗的临床效果。
Objective: To investigate the effect of TP for neoadjuvant chemotherapy on locally advanced cervical cancer.
近年来，随着肿瘤化疗研究的不断进展，宫颈癌的化学治疗尤其是新辅助化疗的应用日益受到人们的重视。
With development in research on chemotherapy of carcinomas in recent years, chemotherapy especially neoadjuvant chemotherapy of cervical cancer has attracted more and more attention.
结论：紫杉醇联合顺铂新辅助化疗方案治疗中晚期食管癌疗效显著。
Conclusion: the combination of paclitaxel and cisplatin was an effective regimen as neoadjuvant chemotherapy for LAEC.
应用推荐